Where does Allele Biotechnology & Pharmaceuticals, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Allele Biotechnology & Pharmaceuticals, Inc. ranks #23,836 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Allele Biotechnology & Pharmaceuticals, Inc. hold?

Allele Biotechnology & Pharmaceuticals, Inc. holds 11 US utility patents granted between 2015 and 2025, spanning 10 technology areas.

What is Allele Biotechnology & Pharmaceuticals, Inc.'s Innovation Score?

Allele Biotechnology & Pharmaceuticals, Inc. has an Innovation Score of 29.5 out of 100 (31st percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Allele Biotechnology & Pharmaceuticals, Inc. focus on?

Allele Biotechnology & Pharmaceuticals, Inc.'s top technology area is C07K (Peptides) with 7 patents, ranking #1,213 of 3,615 assignees active in that subclass. Grants appear in 10 CPC subclasses total.

Is Allele Biotechnology & Pharmaceuticals, Inc.'s patent grant rate increasing or decreasing?

Allele Biotechnology & Pharmaceuticals, Inc.'s recent grant velocity is -71% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Allele Biotechnology & Pharmaceuticals, Inc.'s patents?

Allele Biotechnology & Pharmaceuticals, Inc.'s patents average 12.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView US Corporation

Allele Biotechnology & Pharmaceuticals, Inc.

Q: How is the Allele Biotechnology & Pharmaceuticals, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 11 granted patents across 10 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Allele ranks #23,836 of 49,997 tracked US assignees by granted-patent volume, with 11 patents across 10 technology areas.

#23,836
of 49,997 US assignees by volume: 31st percentile
by Innovation Score (29.5/100): 12.4
avg claims per patent: -71%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R23836 · US Corporation #23,836 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 11 grants
MID-PACK #23,836/49,997
PHOTO-FINISH Aircraft Owners and…
CPC-FOCUS C07K · 10 areas
INNOV-THIN 29.5/100
CLAIMS-RICH 12.4 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -71% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Aircraft Owners and Pilots Association (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Allele’s 29.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.6 pts (29%) Velocity 2.2 pts (7%) Breadth 11.2 pts (38%) Claim depth 7.5 pts (25%)

Qualcomm Incorporated · highest

85
Allele Biotechnology… · this assignee

29
3D Lighting… · lowest

7

What this shows Allele's Innovation Score is 29.5/100 (31st percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Allele?

Each dot is one of Allele’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Allele’s own 12.4 claims/patent is ABOVE the 8.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Allele vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Allele's grants concentrate

Allele Biotechnology & Pharmaceuticals, Inc. is a focused PatentsView assignee: 10 CPC subclasses with 63.6% of grants classified under C07K (Peptides). Peak complete grant year is 2015 (2 grants) versus a trough of 1 in 2017. By volume, Allele sits between Aircraft Owners and Pilots Association and Alpha Primitus, Inc..

Allele's three-year grant acceleration

Allele Biotechnology & Pharmaceuticals, Inc. shows 1 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Aircraft Owners a…

11
Alacritech

11
Alamak Bioscience…

11
Alcohol Counterme…

11
Allen Engineering

11
Allied Air Enterp…

11
Alpha Modus

11
Alpha Primitus

11
Allele Biotechnol… ◀

11

What this shows Allele holds 11 patents at rank #23,897, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Allele

By rank, the assignees closest to #23,897 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in Allele's primary technology class.

Allele's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

29 31st percentile higher than 31% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Allele Biotechnology & Pharmaceuticals, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	18.2%
2017	1	9.1%
2018	2	18.2%
2019	2	18.2%
2020	1	9.1%
2024	1	9.1%
2025partial year	2	18.2%

Which technologies does Allele Biotechnology & Pharmaceuticals, Inc. patent most?

C07K - Peptides 7

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 6

A61Q - Specific USE OF Cosmetics OR Similar Toiletry Preparations 3

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 3

C09C - Treatment OF Inorganic Materials, Other Than Fibrous Fillers, TO Enhance Their Pigmenting OR Filling Properties ; Preparation OF Carbon Black ; ; Preparation OF Inorganic Materials Which ARE NO Single Chemical Compounds AND Which ARE Mainly Used AS Pigments OR Fillers 2

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 2

C09J - ADHESIVES; Non-mechanical Aspects OF Adhesive Processes IN GENERAL; Adhesive Processes NOT Provided FOR ELSEWHERE; USE OF Materials AS Adhesives 1

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 1

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 1

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Allele Biotechnology & Pharmaceuticals, Inc.'s patent record in context - here's where to go next.

Allele Biotechnology & Pharmaceuticals, Inc.'s lead technology class is C07K (Peptides), 63.6% of its portfolio - see every assignee active in that class. Explore C07K
Ranked #23,836 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Allele Biotechnology & Pharmaceuticals, Inc. against Aircraft Owners and Pilots Association, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 29.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.